Vinorelbine and Docetaxel Combination as the First Line Treatment in Patients with Metastatic Breast Cancer: Results of a Multi-centric Phase II Trial in Iran

Abstract

Introduction: We conducted a multi-centric phase II study to evaluate the tumor response and safety of the combination of vinorelbin and docetaxel in treatment of metastatic breast cancer patients.

Description

Keywords

Citation

URI

Endorsement

Review

Supplemented By

Referenced By